Initial single-center experience with a new intracoronary stent.
We investigated the safety and efficacy of the recently introduced intracoronary beStent(TM). High flexibility, zero shortening after expansion and delineating gold markers at either end of the stent are favorable features of this device. Between July 1996 and February 1997, 117 patients received a total of 126 stents, measuring 15, 25 and 35 mm in length. The majority of lesions were located in the LAD (n = 48; 38%), followed by lesions in the RCA (n = 41; 33%) and the circumflex artery (n = 28; 22%). Nine additional stents were delivered into vein grafts (7%). Successful stent deployment was achieved in 94% (n = 118), even in cases with complex lesion morphology and angulated segments. The markers proved to be helpful in placing the stent close to side-branches and whenever serial stents were used. Complications during hospitalization were as follows: one cardiac death unrelated to stenting, one subacute stent thrombosis after 30 min of effective anticoagulation and one Q-wave myocardial infarction due to peripheral thrombus embolization after stent placement in a vein graft. One patient was sent for elective CABG after an unsatisfactory procedural result. Stent loss occurred in four patients, and all stents could be retrieved successfully; in another four patients stent placement at the target site was impossible. We conclude that the investigated stent demonstrates several favorable stent characteristics which have proved to be useful in treating complex lesions by providing favorable acute results with a low complication rate.